Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
10(27%)
Results Posted
27%(3 trials)

Phase Distribution

Ph not_applicable
9
24%
Ph phase_3
1
3%
Ph phase_2
3
8%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
3(23.1%)
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
9(69.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

10

trials recruiting

Total Trials

37

all time

Status Distribution
Active(13)
Completed(11)
Terminated(1)
Other(12)

Detailed Status

unknown12
Completed11
Recruiting7
Active, not recruiting3
Not yet recruiting3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
37
Active
10
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (23.1%)
Phase 31 (7.7%)
N/A9 (69.2%)

Trials by Status

recruiting719%
active_not_recruiting38%
completed1130%
not_yet_recruiting38%
withdrawn13%
unknown1232%

Recent Activity

Clinical Trials (37)

Showing 20 of 37 trialsScroll for more
NCT04262154Phase 2

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Active Not Recruiting
NCT07470138

Sleep Disturbance in Subjects With Autism Spectrum Disorders (ASD) in Preschool Age (18-60 Months)

Recruiting
NCT03785574Not Applicable

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Recruiting
NCT06525532

Clinical-MRI Evaluation in Patients Undergoing Subtalar Arthrorisis With Reabsorbable Endorthesis Implant in PLLA

Recruiting
NCT05299346

Post-ICU Follow-up Study in Covid-19 Patients

Completed
NCT06779344Not Applicable

MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD

Not Yet Recruiting
NCT06636955

Viral Epidemiology of Bronchiolitis After Nirsevimab Implementation and Respiratory Evolution in Infants

Recruiting
NCT05003505

Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection

Active Not Recruiting
NCT05282095

Effect of HPV Integration on Prognosis of Young Women With CIN2 in China

Recruiting
NCT06402175

Characteristics and Outcomes of Patients With Hematological Malignancies

Not Yet Recruiting
NCT06345625

Gait and Postural Balance Analysis During Head-motion Perturbed Standing and Walking in Older Adults

Recruiting
NCT06137352

Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity

Not Yet Recruiting
NCT05283239

Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection

Unknown
NCT05051852

HPV Viral Load in Predicting the Prognosis of LSIL

Unknown
NCT05086991

AIHEMAF - P "An Innovative Healthcare Model for AF Patients"

Completed
NCT06061263

Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy

Unknown
NCT01837745Phase 3

Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?

Active Not Recruiting
NCT03373032Not Applicable

Skin Sensitivity Acupuncture and Kinesiotherapy on Breast Cancer Patients Subject to Chemotherapy With Taxans

Completed
NCT05745597

Prognostic Study of HPV Virus Integration in Women With HSIL

Unknown
NCT05123417Not Applicable

Knowledge and Practices of Preventing Pressure Ulcers

Completed

Drug Details

Intervention Type
OTHER
Total Trials
37